BECAS
DOS SANTOS CÉlia
artículos
DOS SANTOS, CÉLIA; CASTERA, SANTIAGO; FERNANDEZ, JOSÉ; ROSALES, JULIETA SOLEDAD; CRESCITELLI, FRANCO; BOUGHEN, SANTIAGO; IASTREBNER, MARCELO; GUERRERO, OSVALDO; AMELL MENCO, CARLOS; GOMEZ, MARIELA; GONZALEZ, JACQUELINE; ALBERTO, MARIA FABIANA; SANCHEZ-LUCEROS, ANALÍA
Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases
Hematology, Transfusion and Cell Therapy; Año: 2024
DOS SANTOS, CÉLIA; TRINIDAD, JESICA; CASTERA, SANTIAGO; ALCONCHER, LAURA; COCCIA, PAULA ALEJANDRA; MANNI, FEDERICO JAVIER; ALBERTO, MARÍA FABIANA; SÁNCHEZ-LUCEROS, ANALÍA
Anti-factor H autoantibody-associated hemolytic uremic syndrome in an Argentine pediatric cohort
Exploration of Immunology; Año: 2023 vol. 3 p. 513 - 524
WOODS, ADRIANA INÉS; PAIVA, JUVENAL; DOS SANTOS, CELIA; ALBERTO, MARÍA FABIANA; SÁNCHEZ-LUCEROS, ANALÍA
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease
SEMINARS IN THROMBOSIS AND HEMOSTASIS; Año: 2022
CÉLIA DOS SANTOS; JUVENAL PAIVA; MARÍA L ROMERO; MARA AGAZZONI; ANA C KEMPFER; SABRINA ROTONDO; MARÍA M CASINELLI; MARÍA F ALBERTO; ANALÍA SÁNCHEZ-LUCEROS
Thrombotic microangiopathies: First report of 294 cases from a single institution experience in Argentina
eJHaem; Año: 2021
NATALIA MOGOLLÓN MOLINA; SABRINA ROTONDO; CÉLIA DOS SANTOS; ANALÍA SÁNCHEZ-LUCEROS
Biomarcadores y blancos moleculares del complemento en el diagnóstico de las microangiopatías trombóticas
ACTA BIOQUíMICA CLíNICA LATINOAMERICANA; Lugar: La Plata; Año: 2020 vol. 54 p. 437 - 453
DOS SANTOS, CÉLIA; HAMADAT, SABAH; LE SAUX, KAREN; NEWTON, CLARA; MAZOUNI, MERIEM; ZARGARIAN, LOUSSINÉ; MIRO-PADOVANI, MICKAEL; ZADIGUE, PATRICIA; DELBÉ, JEAN; HAMMA-KOURBALI, YAMINA; AMICHE, MOHAMED
Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans
PLOS ONE; Año: 2017 vol. 12
ANALÍA SÁNCHEZ-LUCEROS; CÉLIA DOS SANTOS; ANDREA EXENI; ADRIANA SANTIAGO; RAMÓN EXENI
SÍNDROME URÉMICO HEMOLÍTICO ATÍPICO
Archivos Latinoamericanos de Nefrología Pediátrica; Año: 2017 vol. 17 p. 3 - 16
MARIA SEROVA; ANNEMILAÏ TIJERAS-RABALLAND; CÉLIA DOS SANTOS; MATTHIEU MARTINET; CINDY NEUZILLET; ALFRED LOPEZ; DIANNE C. MITCHELL; BRAD A. BRYAN; GUILLAUME GAPIHAN; ANNE JANIN; GUILHEM BOUSQUET; MARIA EUGENIA RIVEIRO; IVAN BIECHE; SANDRINE FAIVRE; ERIC RAYMOND; ARMAND DE GRAMONT
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
Oncotarget; Año: 2016
C DOS SANTOS; A TIJERAS-RABALLAND; M SEROVA; S SEBBAGH; K SLIMANE; S FAIVRE; A DE GRAMONT; E RAYMOND
Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma
BRITISH JOURNAL OF CANCER; Lugar: Londres; Año: 2015
M SEROVA; A TIJERAS-RABALLAND; CÉLIA DOS SANTOS; M ALBUQUERQUE; V PARADIS; C NEUZILLET; K A BENHADJI; E RAYMOND; S FAIVRE; A DE GRAMONT
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
Oncotarget; Año: 2015
CÉLIA DOS SANTOS; CHARLY BLANC; RANIA ELAHOUEL; MARK PRESCOTT; GILLES CARPENTIER; ALESSANDRO ORI; JOSÉ COURTY; YAMINA HAMMA-KOURBALI; DAVID G. FERNIG; JEAN DELBÉ
Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide
BIOCHIMIE; Lugar: Paris; Año: 2014
MARIA SEROVA; ARMAND DE GRAMONT; ANNEMILAI TIJERAS-RABALLAND; CÉLIA DOS SANTOS; MARIA EUGENIA RIBEIRO; KHEMAIES SLIMANE; SANDRINE FAIVRE; ERIC RAYMOND
Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib
CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Berlin; Año: 2013
HANNEKE VAN ZOGGEL; GILLES CARPENTIER; CÉLIA DOS SANTOS; YAMINA HAMMA-KOURBALI; JOSÉ COURTY; MOHAMED AMICHE; JEAN DELBÉ
Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2
PLOS ONE; Lugar: San Francisco; Año: 2012
CÉLIA DOS SANTOS; RACHA KARAKY; DOMINIQUE RENOIR; YAMINA HAMMA-KOURBALI; PATRICIA ALBANESE; EMILIE GOBBO; FRANK GRISCELLI; PAULE OPOLON; SOPHIE DALLE; MICHEL PERRICAUDET; JOSÉ COURTY; JEAN DELBÉ
Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2010
OYA BERMEK; ZOI DIAMANTOPOULOU; APOSTOLIS POLYKRATIS; CÉLIA DOS SANTOS; YAMINA HAMMA-KOURBALI; FABIENNE BURLINA; JEAN DELBÉ; GÉRARD CHASSAING; DAVID G. FERNIG; PAGNAGIOTIS KATSORIS; JOSÉ COURTY
A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells
EXPERIMENTAL CELL RESEARCH; Lugar: Amsterdam ; Año: 2007